Cidara Therapeutics (CDTX) Tops Q3 EPS by 21c

Cidara Therapeutics (NASDAQ: CDTX) reported Q3 EPS of ($0.73), $0.21 better than the analyst estimate of ($0.94).

For earnings history and earnings-related data on Cidara Therapeutics (CDTX) click here.

You May Also Be Interested In

• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
• S&P 500 above 8,000 in 2026 now looks ambitious, Citi says
• Core & Main, Inc (CNM) Tops Q3 EPS by 2c ; Offers Guidance